Dr Richard K Burt

Professor Burt performed America’s first hematopoietic stem cell transplant (HSCT) for multiple sclerosis (MS), systemic lupus erythematosus (SLE), Crohn’s disease (CD), stiff person syndrome (SPS), and chronic inflammatory demyelinating polyneuropathy (CIDP) and published the world’s first randomized clinical stem cell transplantation trials for systemic sclerosis and multiple sclerosis.

He has been awarded Leukemia Scholar of America, the Lupus Foundation of America Fidelitas Award, the Van Bekkum Award by the European Society for Blood and Marrow Transplantation, the Distinguished Clinical Achievement Award by the Clinical Research Forum, and the European Group for Blood and Marrow Transplantation Clinical Achievement Award. Dr. Burt was presented in Vatican City, Rome with the “Keys to the Vatican”, was speaker at the Festival of Thinkers in Leadership in Healthcare in the United Arab Emirates, and chaired the biotechnology session at the Baku Azerbaijan International Humanitarian Forum. Dr. Burt was recognized by Science Illustrated for accomplishing one of the Top 10 medical breakthroughs for the next ten years, and by Scientific American as one of the Top 50 individuals, teams, or organizations for improving humanity and outstanding leadership.

He supports AIMS and this summit because an enlarging medical bureaucracy's interests are better held accountable and more transparent when patients are engaged and have the knowledge about their disease to provide proper informed consent and select the best treatment option for him or herself.